This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides After being placed into FDA Category 2 in 2023, several widely discussed peptides faced restricted pathways for regulated compounding. This shift pushed demand toward unregulated markets and created significant uncertainty across the Pharmacy Purchasing & Products Magazine FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting RFK Jr. may make it easier to get peptides what do doctors think?